Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting

doi:10.1186/1471-2164-8-267

BMC Genomics

Volume 8

Viewing options:

Abstract
Full text
PDF (441KB)
Additional files

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

van den Bosch HM
Bünger M
de Groot PJ
van der Meijde J
Hooiveld GJ
Müller M

on PubMed

van den Bosch HM
Bünger M
de Groot PJ
van der Meijde J
Hooiveld GJ
Müller M
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Research article

Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting

Heleen M van den Bosch¹^,2 , Meike Bünger¹^,2 , Philip J de Groot¹^,2 , Jolanda van der Meijde¹ , Guido JEJ Hooiveld¹^,2 and Michael Müller¹^,2

¹Nutrition, Metabolism and Genomics group, Division of Human Nutrition, Wageningen, University, Bomenweg 2, 6703 HD Wageningen, The Netherlands

²Nutrigenomics Consortium, TI Food and Nutrition, Wageningen, The Netherlands

author email corresponding author email

BMC Genomics 2007, 8:267doi:10.1186/1471-2164-8-267


Published:	7 August 2007

Abstract

Background

Fasting has dramatic effects on small intestinal transport function. However, little is known on expression of intestinal transport and phase I/II metabolism genes during fasting and the role the fatty acid-activated transcription factor PPARα may play herein. We therefore investigated the effects of fasting on expression of these genes using Affymetrix GeneChip MOE430A arrays and quantitative RT-PCR.

Results

After 24 hours of fasting, expression levels of 33 of the 253 analyzed transporter and phase I/II metabolism genes were changed. Upregulated genes were involved in transport of energy-yielding molecules in processes such as glycogenolysis (G6pt1) and mitochondrial and peroxisomal oxidation of fatty acids (Cact, Mrs3/4, Fatp2, Cyp4a10, Cyp4b1). Other induced genes were responsible for the inactivation of the neurotransmitter serotonin (Sert, Sult1d1, Dtd, Papst2), formation of eicosanoids (Cyp2j6, Cyp4a10, Cyp4b1), or for secretion of cholesterol (Abca1 and Abcg8). Cyp3a11, typically known because of its drug metabolizing capacity, was also increased. Fasting had no pronounced effect on expression of phase II metabolic enzymes, except for glutathione S-transferases which were down-regulated. Time course studies revealed that some genes were acutely regulated, whereas expression of other genes was only affected after prolonged fasting. Finally, we identified 8 genes that were PPARα-dependently upregulated upon fasting.

Conclusion

We have characterized the response to fasting on expression of transporters and phase I/II metabolic enzymes in murine small intestine. Differentially expressed genes are involved in a variety of processes, which functionally can be summarized as a) increased oxidation of fat and xenobiotics, b) increased cholesterol secretion, c) increased susceptibility to electrophilic stressors, and d) reduced intestinal motility. This knowledge increases our understanding of gut physiology, and may be of relevance for e.g. pre-surgery regimen of patients.